All In Biotech

Drug Trial Radar · NCT03302845

A Phase 1 Study to Evaluate the Effects of Omeprazole and Famotidine on the Absorption of Telotristat Ethyl in Healthy Subjects

A Phase 1, Open-label, Parallel Group, Drug-drug Pharmacokinetic Interaction Study to Evaluate the Effects of Multiple-dose Omeprazole and Famotidine on the Absorption of Single-dose Telotristat Ethyl in Healthy Male and Female Subjects

Last checked: Nov 20, 2026Latest source record: Apr 25, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

32

Actual

Start

Sep 21, 2017

Primary completion

Oct 23, 2017

Study completion Nov 7, 2017

Sponsor

Lead sponsor
Lexicon PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Oct 5, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Basic science
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This drug-drug interaction study will evaluate the impact of two different acid reducing agents (from two different drug classes) co-administered with a single dose of telotristat ethyl.

Conditions

  • Drug-drug Interaction

Interventions

  • Omeprazole 40 MGDrug

    Omeprazole 40 mg capsule

  • Famotidine 40 mgDrug

    Famotidine 40 mg tablet

  • Telotristat ethyl 250 mgDrug

    Telotristat ethyl 250 mg tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum observed concentration of telotristat ethylTime frame: 7 days
  2. Time of maximum observed concentration of telotristat ethylTime frame: 7 days
  3. Area under the plasma concentration-time curve beginning from the first dose until the last quantifiable concentration of telotristat ethylTime frame: 7 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Covance Clinical Research Unit

    Dallas, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.